No Article Versions Notes Found

Carpenedo M, Cantoni S, Coccini V, Fedele M, Morra E, Pogliani EM. Feasibility of Romiplostim Discontinuation in Adult Thrombopoietin-Receptor Agonist Responsive Patients with Primary Immune Thrombocytopenia: An Observational Retrospective Report in Real Life Clinical Practice. Hematology Reports. 2015; 7(1):5673. https://doi.org/10.4081/hr.2015.5673

Carpenedo, Monica, Silvia Cantoni, Veronica Coccini, Marilena Fedele, Enrica Morra, and Enrico Maria Pogliani. 2015. "Feasibility of Romiplostim Discontinuation in Adult Thrombopoietin-Receptor Agonist Responsive Patients with Primary Immune Thrombocytopenia: An Observational Retrospective Report in Real Life Clinical Practice" Hematology Reports 7, no. 1: 5673. https://doi.org/10.4081/hr.2015.5673

Carpenedo, M., Cantoni, S., Coccini, V., Fedele, M., Morra, E., & Pogliani, E. M. (2015). Feasibility of Romiplostim Discontinuation in Adult Thrombopoietin-Receptor Agonist Responsive Patients with Primary Immune Thrombocytopenia: An Observational Retrospective Report in Real Life Clinical Practice. Hematology Reports, 7(1), 5673. https://doi.org/10.4081/hr.2015.5673